Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 3,562 RLYB shares, $8.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 3,562 | $8.5K |
| Jun 8, 2026 | Prime Medicine, Inc. (PRME) | Grant/Award | 75,000 | n/a |
| Aug 6, 2025 | Prime Medicine, Inc. (PRME) | Disposition to Issuer | 13,510 | n/a |
| Jun 5, 2025 | Prime Medicine, Inc. (PRME) | Grant/Award | 55,000 | n/a |
| May 15, 2025 | Rallybio Corp (RLYB) | Grant/Award | 28,500 | n/a |
| Jun 14, 2024 | Prime Medicine, Inc. (PRME) | Grant/Award | 45,000 | n/a |
| May 17, 2024 | Rallybio Corp (RLYB) | Grant/Award | 16,500 | n/a |
| Jun 16, 2023 | Prime Medicine, Inc. (PRME) | Grant/Award | 39,062 | n/a |
| May 19, 2023 | Rallybio Corp (RLYB) | Grant/Award | 12,353 | n/a |
| Jan 5, 2023 | Rallybio Corp (RLYB) | Grant/Award | 9,482 | n/a |